Skip to content
← Full study record

NCT01419795 · MORE INFO

Limitations, agreements, and source contact

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant · Source last updated 2017-07-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
msorror@fredhutch.org
organization
Fred Hutchinson Cancer Research Center
phone
206-667-6298
title
Dr. Mohamed Sorror
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
msorror@fredhutch.org
organization
Fred Hutchinson Cancer Research Center
phone
206-667-6298
title
Dr. Mohamed Sorror

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice